Tong Ren Tang CM: No Share Capital Changes, Public Float Fully Compliant in March 2026

Bulletin Express

Apr 02

Beijing Tong Ren Tang Chinese Medicine Company Limited (Tong Ren Tang CM) filed its Monthly Return for the period ended 31 March 2026, confirming a stable share structure and full compliance with Hong Kong Stock Exchange requirements.

Issued Share Capital • Ordinary shares in issue remained unchanged at 837.10 million, with zero treasury shares reported. • No share repurchases, cancellations, or new issuances occurred during the month.

Public Float Status • The company affirmed that it met the Main Board minimum public-float threshold of 25% as at 31 March 2026.

Capital Instruments • No outstanding or newly granted share options, warrants, convertible securities, or other equity-linked instruments were recorded.

Regulatory Confirmation • The submission, dated 02 April 2026 and signed by the Company Secretary, attests that all statutory and listing-rule obligations were satisfied during the reporting period.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/news/1199815359"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1199815359\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1199815359?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-02 17:27","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1199815359","market":"us","top_or_hot":-1,"title":"Tong Ren Tang CM: No Share Capital Changes, Public Float Fully Compliant in March 2026","media":"Bulletin Express","content":"<p>Beijing Tong Ren Tang Chinese Medicine Company Limited (Tong Ren Tang CM) filed its Monthly Return for the period ended 31 March 2026, confirming a stable share structure and full compliance with Hong Kong Stock Exchange requirements.</p>\n<p>Issued Share Capital  \n• Ordinary shares in issue remained unchanged at 837.10 million, with zero treasury shares reported.  \n• No share repurchases, cancellations, or new issuances occurred during the month.</p>\n<p>Public Float Status  \n• The company affirmed that it met the Main Board minimum public-float threshold of 25% as at 31 March 2026.</p>\n<p>Capital Instruments  \n• No outstanding or newly granted share options, warrants, convertible securities, or other equity-linked instruments were recorded.</p>\n<p>Regulatory Confirmation  \n• The submission, dated 02 April 2026 and signed by the Company Secretary, attests that all statutory and listing-rule obligations were satisfied during the reporting period.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tong Ren Tang CM: No Share Capital Changes, Public Float Fully Compliant in March 2026</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTong Ren Tang CM: No Share Capital Changes, Public Float Fully Compliant in March 2026\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-04-02 17:27</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Beijing Tong Ren Tang Chinese Medicine Company Limited (Tong Ren Tang CM) filed its Monthly Return for the period ended 31 March 2026, confirming a stable share structure and full compliance with Hong Kong Stock Exchange requirements.</p>\n<p>Issued Share Capital  \n• Ordinary shares in issue remained unchanged at 837.10 million, with zero treasury shares reported.  \n• No share repurchases, cancellations, or new issuances occurred during the month.</p>\n<p>Public Float Status  \n• The company affirmed that it met the Main Board minimum public-float threshold of 25% as at 31 March 2026.</p>\n<p>Capital Instruments  \n• No outstanding or newly granted share options, warrants, convertible securities, or other equity-linked instruments were recorded.</p>\n<p>Regulatory Confirmation  \n• The submission, dated 02 April 2026 and signed by the Company Secretary, attests that all statutory and listing-rule obligations were satisfied during the reporting period.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03613","symbol_name":"同仁堂国药","start_time":0,"source_url":"","article_id":"1199815359","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1199815359","pubTimestamp":1775122046,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Beijing Tong Ren Tang Chinese Medicine Company Limited (Tong Ren Tang CM) filed its Monthly Return for the period ended 31 March 2026, confirming a stable share structure and full compliance with...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03613":"同仁堂国药"},"translate_title":"同仁堂CM：无股本变动，2026年3月公众持股量全面合规","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03613":1},"content_text":"Beijing Tong Ren Tang Chinese Medicine Company Limited (Tong Ren Tang CM) filed its Monthly Return for the period ended 31 March 2026, confirming a stable share structure and full compliance with Hong Kong Stock Exchange requirements.\nIssued Share Capital  \n• Ordinary shares in issue remained unchanged at 837.10 million, with zero treasury shares reported.  \n• No share repurchases, cancellations, or new issuances occurred during the month.\nPublic Float Status  \n• The company affirmed that it met the Main Board minimum public-float threshold of 25% as at 31 March 2026.\nCapital Instruments  \n• No outstanding or newly granted share options, warrants, convertible securities, or other equity-linked instruments were recorded.\nRegulatory Confirmation  \n• The submission, dated 02 April 2026 and signed by the Company Secretary, attests that all statutory and listing-rule obligations were satisfied during the reporting period.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}